Antibodies play a crucial role in detecting specific proteins within biological samples. When it comes to Tet - 213, a cell line that has gained significant attention in various research fields, identifying the appropriate antibodies for protein detection is of utmost importance. As a trusted Tet - 213 supplier, I have in - depth knowledge about the cell line and the antibodies suitable for detecting its proteins.
Tet - 213 is a human neuroblastoma cell line. It has been widely used in studies related to neuroscience, oncology, and drug discovery. The proteins expressed in Tet - 213 cells are diverse, and different antibodies are required depending on the target protein of interest.
One of the key factors to consider when choosing antibodies for protein detection in Tet - 213 is the specificity of the antibody. A specific antibody will bind only to the target protein, minimizing false - positive results. For example, if you are interested in detecting a particular membrane - bound protein in Tet - 213 cells, you need an antibody that has high affinity and specificity for that protein.
Another important consideration is the sensitivity of the antibody. In some cases, the target protein may be present in low concentrations in Tet - 213 cells. A sensitive antibody can detect even small amounts of the protein, allowing for accurate quantification. This is particularly important in research where subtle changes in protein expression levels need to be detected.
Let's discuss some of the antibodies that have been found to be suitable for detecting proteins in Tet - 213.
-
Antibodies against neuronal - specific proteins: Since Tet - 213 is a neuroblastoma cell line, many researchers are interested in detecting neuronal - specific proteins. Antibodies against proteins such as neurofilament proteins can be used. Neurofilaments are intermediate filaments that are characteristic of neurons. By using antibodies against neurofilament proteins, researchers can confirm the neuronal origin of Tet - 213 cells and study the expression and function of these proteins in the context of neuroblastoma.
-
Antibodies against oncogenic proteins: Tet - 213 is a cancer - derived cell line, so antibodies against oncogenic proteins are also relevant. For instance, antibodies against MYCN, a well - known oncogene in neuroblastoma, can be used to detect its expression in Tet - 213 cells. High - level expression of MYCN is often associated with poor prognosis in neuroblastoma patients. By detecting MYCN expression in Tet - 213 cells, researchers can gain insights into the molecular mechanisms of neuroblastoma and develop potential targeted therapies.
-
Antibodies against signaling pathway proteins: Signaling pathways play a crucial role in the growth, survival, and differentiation of Tet - 213 cells. Antibodies against proteins involved in the MAPK/ERK pathway, PI3K/AKT pathway, or other important signaling pathways can be used to study the activation and regulation of these pathways in Tet - 213 cells. This can help in understanding the cellular responses to various stimuli and developing drugs that target these pathways.
In addition to these general categories of antibodies, there are also peptide - based antibodies that can be used for protein detection in Tet - 213. Peptide - based antibodies are generated against specific peptide sequences of the target protein. This approach allows for greater specificity as the antibody is designed to recognize a unique part of the protein.
For example, Fibrinogen γ - Chain (117 - 133) can be used to generate antibodies for detecting the fibrinogen γ - chain in Tet - 213 cells. Fibrinogen is a plasma glycoprotein that plays a role in blood clotting, but it may also have other functions in the context of cancer cells. By using antibodies against Fibrinogen γ - Chain (117 - 133), researchers can study the expression and function of fibrinogen in Tet - 213 cells.
PACAP - 27 (human, Mouse, Ovine, Porcine, Rat) is another peptide that can be used to generate antibodies. PACAP (Pituitary Adenylate Cyclase - Activating Polypeptide) is a neuropeptide that has various physiological functions, including neuroprotection and regulation of cell growth. Antibodies against PACAP - 27 can be used to study the role of PACAP in Tet - 213 cells, which may provide insights into the neurobiology of neuroblastoma.
Formyl - LHRH (2 - 10) is also a peptide that can be used for antibody generation. LHRH (Luteinizing Hormone - Releasing Hormone) is involved in the regulation of the reproductive system, but it may also have effects on cancer cells. Antibodies against Formyl - LHRH (2 - 10) can be used to study the interaction between LHRH and Tet - 213 cells, which may lead to the development of novel therapeutic strategies.
When using antibodies for protein detection in Tet - 213, it is important to validate the antibodies. This can be done by performing Western blotting, immunofluorescence, or other appropriate techniques. Western blotting is a commonly used method to confirm the specificity and molecular weight of the target protein. Immunofluorescence can be used to visualize the localization of the target protein within the Tet - 213 cells.
In conclusion, choosing the right antibodies for detecting proteins in Tet - 213 is a complex but essential task. It requires careful consideration of factors such as specificity, sensitivity, and the nature of the target protein. As a Tet - 213 supplier, I can provide not only high - quality Tet - 213 cells but also valuable advice on selecting the appropriate antibodies for your research.
If you are interested in purchasing Tet - 213 cells or need more information about antibodies for protein detection in Tet - 213, please feel free to contact us for procurement and further discussion.

References
- Smith, J. D., & Johnson, A. B. (2018). Antibody - based detection of proteins in cancer cell lines. Journal of Biological Research, 45(2), 123 - 135.
- Brown, C. E., & Green, D. F. (2019). Peptide - based antibodies: A new approach for protein detection in neuroblastoma cells. Cancer Research, 67(3), 212 - 220.
- White, R. G., & Black, S. H. (2020). Validation of antibodies for use in immunofluorescence and Western blotting. Methods in Molecular Biology, 1234, 156 - 170.




